1,042 results on '"Murrell, Dedee F"'
Search Results
2. Dermatology Journal Advisory Boards and editorial independence
3. Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study
4. A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists
5. Fibrillar matrix, Echogenicity, Contour, Thickness, and Suture (FECTS) vs. Global: A comparison of 2 scales developed to assess ultrasound images post rotator cuff repair
6. Diagnosis and management of pemphigus: Recommendations of an international panel of experts
7. Microorganisms in Pathogenesis and Management of Bullous Pemphigoid
8. Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study
9. The Importance of Cardiac Assessment in the Era of Biologic Therapies for Psoriasis
10. COVID-19
11. Cardiac Involvement in Epidermolysis Bullosa
12. Cross‐sectional burden‐of‐illness study in atopic dermatitis (MEASURE‐AD) in Australia and New Zealand reveals impacts on well‐being
13. Editorial: Pemphigus and pemphigoid diseases: in memoriam Detlef Zillikens
14. Gender equity in academic dermatology: Problems aplenty, yet paths ahead
15. Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
16. How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey
17. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex
18. A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa
19. Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study
20. Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference
21. S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology
22. Evaluating diversity in Clinics in Dermatology: Diversity in clinics in dermatology: M. Sun et al.
23. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey
24. Meeting report: Women’s Dermatology Society Forum at the 25th World Congress of Dermatology, Singapore, 2023
25. Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+)
26. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy
27. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
28. Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
29. Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy
30. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
31. The road to publication: Advice from journal editors.
32. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
33. A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
34. The Importance of Patient-Focused Drug Development in Pemphigus and Pemphigoid
35. Topical Corticosteroids in Blistering Diseases
36. Bullous Diseases in Dark Skin
37. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
38. Pharmacological advances in pemphigus
39. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores
40. Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
41. Interventions for bullous pemphigoid
42. Dermatology Journal Advisory Boards and Editorial Independence
43. A 52-Year-Old Italian Male with Widespread Blistering and Erosions Refractory to Regular Dose Prednisone
44. A Man with a Blistering Rash
45. A 57 Year Old Woman with Widespread Scales and Scattered Erosions
46. A 71-Year-Old Man with Blisters on the Face and a Painful Left Thigh
47. Management of Bullous Pemphigoid
48. The Pathogenesis, Assessment and Management of Pruritus in Autoimmune Bullous Diseases
49. Treatment and Prevention of Glucocorticoid-Induced Osteoporosis
50. Quality of Life in Autoimmune Blistering Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.